E-cadherin Immunoexpression Patterns in Gastric Carcinoma Histological Subtypes: A Hospital-based Descriptive Study

被引:0
作者
Divyagna, T. [1 ,2 ]
Jyothi, Chityala [1 ]
Yelavath, Kavitha [1 ]
Banuri, Swapna Kumari [1 ]
Rakam, Sowjanya [1 ]
Goud, S. Divya [1 ]
Toopali, Kavitha [1 ]
Sreelakshmi, I [1 ]
机构
[1] Gandhi Med Coll, Dept Pathol, Hyderabad, Telangana, India
[2] 48-42-1 Janahitha Dent Clin, Hyderabad, Telangana, India
关键词
Adenocarcinoma; Epithelial cadherin; Immunohistochemistry; CELL-CELL-ADHESION; CLINICOPATHOLOGICAL FEATURES; GENE-MUTATIONS; EXPRESSION; DIFFUSE; CANCER; INVASION; CATENIN; COMPLEX;
D O I
10.7860/JCDR/2023/60578.17542
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Gastric carcinoma is the second common Gastrointestinal (GIT) malignancy. Based on Global Cancer Observatory (GLOBOCAN) 2020 data, it is the 5th most common neoplasm and the 4th most common cause of death. Epithelial-cadherin (E-cadherin) is a transmembrane glycoprotein which plays a crucial role in maintaining cell-cell adhesion. Loss of E-cadherin contributes to enhanced invasion and metastasis in human cancers. Aim: To study E-cadherin immunohistochemical expression in tumour cells and its association with gastric carcinoma histotypes. Materials and Methods: It is a hospital-based descriptive study conducted at Department of Pathology, Osmania General Hospital, Hyderabad, Telangana, India from January 2010 to December 2012 as it was my dissertation. Routine histopathology and immunohistochemistry for E-cadherin were done on the sections. E-cadherin immunohistochemical staining and expression in tumour cells were evaluated according to the study by Jawhari A et al., Scores (0-3) were applied: 0-No staining; 1-Only cytoplasmic staining; 2-Cytoplasmic and membranous staining in the same case, 3-Normal membranous immunoexpression. Staining was evaluated based on absence of membranous expression scores (0 and 1) versus the presence of membranous expression (scores 2 and 3). Statistical analysis of the data was done by Chi-square test using Epi Info software.Results: Total 70 cases were studied, of which 48 were gastric biopsies and 22 were gastrectomies. Gastric adenocarcinomas were classified as intestinal 40 cases (57.14%) and diffuse 30 cases (42.85%) according to Lauren's classification. Membranous staining of E-cadherin was seen in 34/40 cases (85%) of intestinal gastric cancer and 9/30 cases (30%) of diffuse intestinal cancer whereas non membranous or absent E-cadherin was seen in 6/40 cases (15%) of intestinal gastric cancer and 21/30 cases (70%) of diffuse gastric cancer. In this study, significant association was found between membranous E-cadherin expression (score 2 or 3) and intestinal histotype and absence of membranous expression (scores 0 or 1) and the diffuse histotype of gastric cancer.Conclusion: Normal gastric mucosa shows strong membranous E-cadherin positivity. There is a change in the pattern of E-cadherin expression from membranous in intestinal type gastric adenocarcinoma to non membranous expression of E-cadherin in diffuse type of gastric carcinoma.
引用
收藏
页码:EC31 / EC35
页数:5
相关论文
共 44 条
  • [11] Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma
    Fricke, E
    Keller, G
    Becker, I
    Rosivatz, E
    Schott, C
    Plaschke, S
    Rudelius, M
    Hermannstädter, C
    Busch, R
    Höfler, H
    Becker, KF
    Luber, B
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (01) : 60 - 65
  • [12] E-CADHERIN-MEDIATED CELL CELL-ADHESION PREVENTS INVASIVENESS OF HUMAN CARCINOMA-CELLS
    FRIXEN, UH
    BEHRENS, J
    SACHS, M
    EBERLE, G
    VOSS, B
    WARDA, A
    LOCHNER, D
    BIRCHMEIER, W
    [J]. JOURNAL OF CELL BIOLOGY, 1991, 113 (01) : 173 - 185
  • [13] Gabbert HE, 1996, INT J CANCER, V69, P184, DOI 10.1002/(SICI)1097-0215(19960621)69:3<184::AID-IJC6>3.0.CO
  • [14] 2-W
  • [15] HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
    Gravalos, C.
    Jimeno, A.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (09) : 1523 - 1529
  • [16] Regulation of cadherin adhesive activity
    Gumbiner, BM
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 148 (03) : 399 - 403
  • [17] Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival
    Jawhari, A
    Jordan, S
    Poole, S
    Browne, P
    Pignatelli, M
    Farthing, MJG
    [J]. GASTROENTEROLOGY, 1997, 112 (01) : 46 - 54
  • [18] Prognostic significance of E-cadherin/catenin complex expression in gastric cancer
    Joo, YE
    Park, CS
    Kim, HS
    Choi, SK
    Rew, JS
    Kim, SJ
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2000, 15 (06) : 655 - 666
  • [19] Karayiannakis AJ, 1998, HEPATO-GASTROENTEROL, V45, P2437
  • [20] Kishan J, 2019, EXPRESSION E CADHERI, V8